S Qu, S Qi, H Zhang, Z Li, K Wang, T Zhu, R Ye… - Journal of Experimental …, 2023 - Springer
Background Temozolomide (TMZ) treatment efficacy in glioblastoma (GBM) patients has
been limited by resistance in the clinic. Currently, there are no clinically proven therapeutic …